Merck & Co Inc logo

Merck & Co Inc

32
7
NYSE:MRK (USA)  
$ 103.67 -0.21 (-0.2%) 09:46 AM EST
On watch
57.59
P/B:
6.37
Market Cap:
$ 262.70B
Enterprise V:
$ 289.19B
Volume:
1.58M
Avg Vol (2M):
7.90M
Also Trade In:
Volume:
1.58M
Avg Vol (2M):
7.90M

Business Description

Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Financials (Next Earnings Date:2024-02-02 Est.)

MRK's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NYSE:MRK

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Merck & Co Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 59,314
EPS (TTM) ($) 1.8
Beta 0.31
Volatility % 15.41
14-Day RSI 52.91
14-Day ATR ($) 1.697434
20-Day SMA ($) 102.571
12-1 Month Momentum % -5.53
52-Week Range ($) 96.36 - 119.65
Shares Outstanding (Mil) 2,534.02

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Merck & Co Inc Filings

Filing Date Document Date Form
No Filing Data

Merck & Co Inc Stock Events

Event Date Price($)
No Event Data

Merck & Co Inc Frequently Asked Questions

What is Merck & Co Inc(MRK)'s stock price today?
The current price of MRK is $103.67. The 52 week high of MRK is $119.65 and 52 week low is $96.36.
When is next earnings date of Merck & Co Inc(MRK)?
The next earnings date of Merck & Co Inc(MRK) is 2024-02-02 Est..
Does Merck & Co Inc(MRK) pay dividends? If so, how much?
The  Dividend Yield %  of Merck & Co Inc(MRK) is 2.82% (As of Today), Highest Dividend Payout Ratio of Merck & Co Inc(MRK) was 1.62. The lowest was 0.37. And the median was 0.49. The  Forward Dividend Yield % of Merck & Co Inc(MRK) is 2.97%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1